Comparison of In Vitro Activity of Cephalexin, Cephradine, and Cefaclor
- 1 March 1977
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 11 (3) , 470-474
- https://doi.org/10.1128/aac.11.3.470
Abstract
Inhibitory activity of cephalexin, cephradine, and cefaclor was compared by the WHO-ICS agar dilution technique. Cefaclor was substantially more active against staphylococci, streptococci, gonococci, meningococci, Haemophilus, Escherichia coli, Klebsiella pneumoniae, Citrobacter diversus, Proteus mirabilis , salmonellae, and shigellae than was cephalexin, which in turn was more active than cephradine. Cefaclor appeared to be less resistant to staphylococcal penicillinase than did the other two agents. None of these cephalosporins was active against Enterobacter, Serratia , indole-positive Proteeae, Pseudomonas , or Bacteroides fragilis .Keywords
This publication has 9 references indexed in Scilit:
- Double-blind comparison of cephradine and cephalexin in the treatment of skin and soft-tissue infections due to Staphylococcus aureus.1976
- Relative Inactivation by Staphylococcus aureus of Eight Cephalosporin AntibioticsAntimicrobial Agents and Chemotherapy, 1976
- Spurious Ampicillin Resistance by Testing Haemophilus influenzae with Agar Containing Supplement CAntimicrobial Agents and Chemotherapy, 1976
- Effect of Inoculum and of Beta-Lactamase on the Anti-Staphylococcal Activity of Thirteen Penicillins and CephalosporinsAntimicrobial Agents and Chemotherapy, 1975
- Hemophilus influenzae type B susceptibility to 17 antibioticsThe Journal of Pediatrics, 1975
- Antimicrobial Susceptibility of Haemophilus influenzaeAntimicrobial Agents and Chemotherapy, 1974
- Antibiotic susceptibility of gram-negative bacilli isolated from blood cultures: Results of tests with 35 agents and strains from 169 patients at Boston City Hospital during 1972The American Journal of Medicine, 1974
- Clinical evaluation of cephradine, a new oral cephalosporinThe Lancet Healthy Longevity, 1974
- CephradineChemotherapy, 1973